Medical Bulletin 12/May/2026

Here are the top medical news for today:

Consistent Daily 8,500-Step Goal May Reduce Chances of Weight Regain, Study Finds

A simple daily habit may be one of the strongest defenses against weight regain after dieting. New research presented at the 2026 European Congress on Obesity suggests that walking around 8,500 steps a day can help people maintain weight loss long term — a challenge that has frustrated both patients and doctors for decades.

Researchers from the University of Modena and Reggio Emilia reviewed 18 clinical trials involving adults with overweight or obesity. Fourteen of those studies, covering nearly 3,800 participants, were included in a detailed meta-analysis. The findings showed that people who increased their daily step count during weight-loss programs were more successful at keeping the weight off afterward.

At the beginning of the studies, participants averaged about 7,200 steps a day. Those enrolled in lifestyle modification programs — which combined diet changes with walking goals — increased their activity to roughly 8,500 daily steps during the weight-loss phase. On average, they lost about 4 kilograms and, importantly, maintained most of that loss over time by continuing to walk around 8,200 steps per day during the maintenance phase.

In contrast, people in the control groups, who did not increase their activity levels, showed little to no meaningful weight loss.

Researchers found that higher step counts were especially important for preventing weight regain rather than boosting initial weight loss. Calorie reduction still appeared to play the larger role during the active dieting phase. However, maintaining regular movement afterward helped stop the body from drifting back toward previous weight levels.

Nearly 80% of people who lose weight eventually regain some or all of it within several years, making long-term maintenance the biggest obstacle in obesity treatment. The study suggests that walking approximately 8,500 steps daily may offer a practical, low-cost strategy to preserve weight loss.

REFERENCE: Saadeddine, D.; Foglia, M.; Berri, E.; Raggi, S.; Itani, L.; El Ghoch, M. Daily Steps During Nutritional Lifestyle Modification Programs for Obesity Management: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health 2026, 23, 522. https://doi.org/10.3390/ijerph23040522

Researchers Discover Gene Linked to Future Possibility of Human Limb Regeneration

A tiny salamander that can regrow an entire limb may have just revealed one of the biggest clues yet for future human regeneration therapies. Scientists studying axolotls, zebrafish, and mice have identified a shared group of genes that appear to control how damaged tissues regrow — a discovery that could eventually help researchers develop treatments for regenerating human limbs.

The study was published in the Proceedings of the National Academy of Sciences. The research team compared regeneration across three species known for their remarkable healing abilities: Mexican axolotl salamanders, zebrafish, and mice.

Axolotls can regrow entire limbs, tails, spinal cord tissue, and even parts of organs. Zebrafish can regenerate damaged fins, heart tissue, and parts of the nervous system. Mice, while far more limited, can still regrow the tips of injured digits — trait humans partially share under certain conditions.

Researchers discovered that all three species activated two genes, called SP6 and SP8, during regeneration. These genes became highly active in the epidermis, the outer tissue layer covering injured areas. The finding suggested that regeneration may rely on a shared biological program that exists across very different animals.

To test the role of these genes, scientists used CRISPR gene-editing technology to remove SP8 in axolotls. Without it, the salamanders failed to properly regrow limb bones. Similar defects were observed in mice when SP6 and SP8 were disrupted.

The team then went a step further. Using a gene therapy approach based on zebrafish research, scientists delivered a signaling molecule called FGF8 into injured mouse tissue. The therapy stimulated bone regrowth and partially restored regenerative abilities in mice lacking the SP genes.

Researchers caution that human limb regeneration remains far from reality. Still, the study offers strong evidence that universal genetic programs may control tissue regrowth across species. Scientists believe future therapies could one day mimic these pathways to repair severe injuries, improve recovery after amputations, and potentially restore lost function in humans.

REFERENCE: David A. Brown, Katja K. Koll, Erin Brush, Grant Darner, Timothy Curtis, Thomas Dvergsten, Melissa Tran, Colleen Milligan, David W. Wolfson, Trevor J. Gonzalez, Sydney Jeffs, Alyssa Ehrhardt, Rochelle Bitolas, Madeleine Landau, Kendall Reitz, David S. Salven, Leslie A. Slota-Burtt, Isabel Snee, Elena Singer-Freeman, Sayuri Bhatia, Jianhong Ou, Aravind Asokan, Joshua D. Currie, Kenneth D. Poss. Enhancer-directed gene delivery for digit regeneration based on conserved epidermal factors. Proceedings of the National Academy of Sciences, 2026; 123 (17) DOI: 10.1073/pnas.2532804123

Scientists Discover Longevity Gene Therapy That Successfully Extends Lifespan in Study

Nature may already hold some of the secrets to healthy aging — hidden inside a nearly hairless rodent that barely seems to age at all. Scientists have now shown that a longevity-related gene from the naked mole rat can actually improve health and extend lifespan in mice, offering one of the clearest signs yet that aging mechanisms from long-lived animals might someday help humans too.

Researchers at University of Rochester transferred a gene linked to the naked mole rat’s unusually high production of high molecular weight hyaluronic acid (HMW-HA) into mice. The study, published in Nature in 2023, found that the modified mice lived healthier lives and showed a roughly 4.4% increase in median lifespan.

Naked mole rats have fascinated scientists for years because they can live up to 41 years — nearly ten times longer than similarly sized rodents — while showing remarkable resistance to cancer, chronic inflammation, cardiovascular disease, and neurodegeneration.

The key molecule in this study, HMW-HA, appears to play a major protective role. Naked mole rats naturally produce around ten times more of it than mice or humans. Previous studies showed that removing HMW-HA from naked mole rat cells made them more vulnerable to tumor formation.

To test whether this protection could transfer to another species, researchers engineered mice with the naked mole rat version of the hyaluronan synthase 2 gene, which boosts production of HMW-HA. The modified mice developed stronger resistance to spontaneous tumors and chemically induced skin cancer. They also experienced lower levels of age-related inflammation and maintained healthier gut function as they aged.

Researchers caution that no single gene will become a “fountain of youth.” Still, the findings suggest that evolution may have already solved some biological problems tied to aging. By studying species that naturally resist disease and decline, scientists hope to uncover therapies that could one day improve human healthspan and delay age-related illness.

REFERENCE: Zhihui Zhang, Xiao Tian, J. Yuyang Lu, Kathryn Boit, Julia Ablaeva, Frances Tolibzoda Zakusilo, Stephan Emmrich, Denis Firsanov, Elena Rydkina, Seyed Ali Biashad, Quan Lu, Alexander Tyshkovskiy, Vadim N. Gladyshev, Steve Horvath, Andrei Seluanov, Vera Gorbunova. Increased hyaluronan by naked mole-rat Has2 improves healthspan in mice. Nature, 2023; 621 (7977): 196 DOI: 10.1038/s41586-023-06463-0